The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status-Reference-Cited by-同舟云学术

The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status

Published:2010-12-23 Issue:26 Volume:116 Page:6147-6148
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Díaz-Beyá Marina¹,Rozman María²,Pratcorona Marta²,Torrebadell Montserrat²,Camós Mireia²,Aguilar Josep Ll.³,Esteve Jordi⁴

Affiliation:

1. Hematology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain

2. Hematology Department, Hematopathology Unit, IDIBAPS, Hospital Clínic, Barcelona, Spain

3. Hematopathology Unit, IDIBAPS, Hospital Clínic, Barcelona, Spain

4. Hematology Department, IDIBAPS, Hospital Clínic, Barcelona, Spain

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/116/26/6147/1491587/zh805210006147.pdf

Reference6 articles.

1. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.;Haferlach;J Clin Oncol,2003

2. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.;Arber;Am J Clin Pathol,2003

3. MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients.;Wandt;Blood,2008

4. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.;Weinberg;Blood,2009

5. Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).;Falini;Blood,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML;European Journal of Haematology;2024-08-08

2. Updates in molecular genetics of acute myeloid leukemia;Seminars in Diagnostic Pathology;2023-05

3. The need for rapid cytogenetics in the era of unique therapies for acute myeloid leukemia;Blood Advances;2022-12-27

4. Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC ‐defining criteria, TP53 allelic state, or TP53 variant allele frequency;Cancer Medicine;2022-11-16

5. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data;Blood;2022-09-15